2020
DOI: 10.1016/j.ancard.2020.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Pandémie COVID-19 : impact sur le systeme cardiovasculaire. Données disponibles au 1er avril 2020

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 38 publications
0
3
0
Order By: Relevance
“…This difference could be explained by diagnostic errors due to Covid-19 delaying ECG recording. The recommended delay between PCM and ECG recording should be less than 10 min according to ESC recommendations [17]. Measures should be taken to reduce this first step of the system delay that is more easily improved than the patient delay.…”
Section: Discussionmentioning
confidence: 99%
“…This difference could be explained by diagnostic errors due to Covid-19 delaying ECG recording. The recommended delay between PCM and ECG recording should be less than 10 min according to ESC recommendations [17]. Measures should be taken to reduce this first step of the system delay that is more easily improved than the patient delay.…”
Section: Discussionmentioning
confidence: 99%
“…And perhaps the most important one, can lives be saved without killing the economy? There are also many unknown unknowns, such as the recent understanding that the lungs are not the only target organ (El Boussadani et al, 2020;Magro et al, 2020;Matías-Guiu et al, 2020;Yao et al, 2020). This raises the question of whether Covid-19 is a systemic disease, something supported by reports of cardiac involvement, embolism and hypotension, which has changed about 5% of all cases into life-threatening emergencies (Wadman et al, 2020).…”
Section: Critical Questionsmentioning
confidence: 99%
“…Elderly patients with a cardiovascular history appear to be more affected with a poor prognosis than in the absence of cardiovascular disease as reported in the literature. Indeed, SARS-CoV-2 has a dual effect at the cardiovascular level: the infection will be more intense if the host has cardiovascular comorbidities and the virus itself can cause potentially fatal cardiovascular damage [18]. In a study of 138 cases of SARS-CoV-2 infection in the Wuhan region of China, 64 patients (46.4%) had at least one predominantly CV comorbidity, hypertension was present in 31.2% of subjects, diabetes in 10.1% of subjects and cardiovascular infection in 14.5% of patients [19].…”
Section: The Patient's Clinical Symptomatology and Medical Historymentioning
confidence: 99%